U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07441200) titled 'Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)' on Jan. 30.
Brief Summary: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Trial to Evaluate the Efficacy and Safety of Orally Administered NS-863 in Participants with Pulmonary Arterial Hypertension (PAH)
Study Start Date: July 01, 2026
Study Type: INTERVENTIONAL
Condition:
Pulmonary Arterial Hypertension
Intervention:
DRUG: NS-863 Low Dose
NS-863 is an orally administered drug
DRUG: NS-863 High Dose
NS-863 is an orally administered drug
DRUG: NS-863 Placebo
An orally administered NS-863 matching placebo
Recruitmen...